China NMPA Drug Inspection - Sichuan Pharmaceutical Co., Ltd. - Yankening tablets

This document outlines an announcement from the Shandong Provincial Food and Drug Administration, dated December 4, 2017, regarding four batches of drugs that failed quality inspections. Inspections, conducted by the Linyi Municipal Food and Drug Inspection and Testing Center, revealed substandard quality across products from three companies.

The implicated companies are Jilin Tianguang Pharmaceutical Co., Ltd., Jilin Jichun Pharmaceutical Co., Ltd., and Sichuan Sanxingdui Pharmaceutical Co., Ltd. Specific violations included Vitiligo Pills (batch numbers 20151102, 20160601) from Jilin Tianguang, Niuhuang Jiedu Pills (batch number 160202) from Jilin Jichun, and Yankening Tablets (batch number 160202) from Sichuan Sanxingdui. These products did not meet established quality standards.

Operating under China's drug regulatory framework, relevant municipal food and drug administration bureaus took immediate action. These actions included sealing off products, seizing existing inventory, suspending sales, and initiating recalls for all affected batches. Additionally, legal investigations and prosecutions have been launched against the manufacturers and units involved. The administration also mandated enhanced supervision of these companies and products, requiring them to investigate the root causes of the quality issues, implement corrective measures, and effectively eliminate potential risks to public health.